Clinical trial
A Randomized, Double-blind, Vehicle Controlled Study of the Safety and Efficacy of Topical DRM02 in Subjects With Plaque Psoriasis
NCT01993433 is registered in ClinicalTrials.gov with Dermira, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Vehicle Controlled Study of the Safety and Efficacy of Topical DRM02 in Subjects With Plaque Psoriasis
- Lead sponsor
- Dermira, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- March 31, 2014
- Enrollment
- 23 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.